multiple myeloma
-
healthJ&J's Haematology Chief Discusses Myeloma Therapy Advances at EHA 2026
Johnson & Johnson's Ester in 't Groen details how T-cell therapies, like bispecifics and CAR-T, are transforming multiple myeloma treatment and extending patient survival.
-
healthJohnson & Johnson CEO Predicts Cancer Cures Within Next Decade
J&J Chairman Joaquin Duato outlines a realistic ten-year timeline for curing specific cancers and converting others into manageable chronic conditions through immunotherapy and AI.
-
healthTalquetamab Combinations Set New Standard in Relapsed Myeloma Care
Phase 3 MonumenTAL-3 trial data reveals talquetamab regimens sharply cut progression risk in relapsed refractory multiple myeloma, delivering deep and durable responses.
-
healthCancer, Loss, and the Art of Gratitude: One Educator’s Journey
After battling multiple myeloma and losing her husband, educator Wong Ching Yee finds healing through art, transforming grief into gratitude.
-
healthEli Lilly Acquires Kelonia Therapeutics for Up to $7 Billion in Cancer Therapy Push
Eli Lilly announces a major acquisition of Kelonia Therapeutics for up to $7 billion, bolstering its cell therapy pipeline with a novel in vivo cancer treatment.
-
healthDiet's Limited Impact on MGUS Risk Revealed in New Study
New nationwide screening data shows diet has minimal impact on monoclonal gammopathy of undetermined significance (MGUS) risk, with a minor exception for dairy intake.
-
healthHope Over Fear: A Mother’s Battle With Multiple Myeloma
Keirney Rimlinger shares her journey with high-risk smoldering multiple myeloma, treatment breakthroughs, and the power of hope in recovery.
-
healthMultiple Myeloma: Early Signs and Treatment Advances
A rare blood cancer affecting plasma cells, multiple myeloma requires early detection. Learn key symptoms, diagnostic criteria, and cutting-edge treatments like CAR-T therapy.